| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9814 |
| Human Intestinal Absorption | HIA+ | 0.9862 |
| Caco-2 Permeability | Caco2- | 0.5087 |
| P-glycoprotein Substrate | Substrate | 0.6315 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6518 |
| Inhibitor | 0.5991 |
| Renal Organic Cation Transporter | Inhibitor | 0.6706 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6973 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8848 |
| CYP450 2D6 Substrate | Non-substrate | 0.5000 |
| CYP450 3A4 Substrate | Non-substrate | 0.5714 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8906 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6520 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8377 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5372 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8033 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9223 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5443 |
| Inhibitor | 0.8653 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.8876 |
| Fish Toxicity | Low FHMT | 0.6224 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9775 |
| Honey Bee Toxicity | Low HBT | 0.9229 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | II | 0.7458 |
| Carcinogenicity (Three-class) | Non-required | 0.5637 |